U
Better Therapeutics, Inc. BTTX
$0.0002 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -36.44% -10.69% -2.40% -8.30% 137.07%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -51.43% -26.82% -4.49% -31.25% 22.25%
Operating Income 51.43% 26.82% 4.49% 31.25% -22.25%
Income Before Tax 48.61% 23.57% 3.17% 36.96% 8.50%
Income Tax Expenses 0.00% -- -- 233.33% --
Earnings from Continuing Operations 48.60% 23.56% 3.16% 36.92% 8.47%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 48.60% 23.56% 3.16% 36.92% 8.47%
EBIT 51.43% 26.82% 4.49% 31.25% -22.25%
EBITDA 56.32% 30.40% 5.90% 31.22% -21.64%
EPS Basic 68.36% 42.23% 4.85% 42.83% 59.76%
Normalized Basic EPS 68.38% 42.24% 4.85% 47.73% 58.47%
EPS Diluted 68.36% 42.23% 4.85% 42.83% 59.76%
Normalized Diluted EPS 68.38% 42.24% 4.85% 47.73% 58.47%
Average Basic Shares Outstanding 62.47% 32.31% 1.77% 20.62% 120.34%
Average Diluted Shares Outstanding 62.47% 32.31% 1.77% 20.62% 120.34%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings